Ultomiris Drug Market: Driving Innovation in Rare Disease Treatment The global pharmaceutical landscape has been witnessing significant advancements in recent years, particularly in the treatment of rare and ultra-rare diseases. One such breakthrough therapy that has gained attention is Ultomiris (ravulizumab-cwvz), developed by Alexion Pharmaceuticals (now part of AstraZeneca). As...